| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.882 | 2 | 4 | 1990 | 2019 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.390 | None | 0.944 | 2 | 3 | 2008 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.160 | None | 1.000 | 1 | 2 | 1991 | 2018 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.200 | None | 0.786 | 1 | 1 | 1993 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 3 | 1 | 1991 | 2016 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1978 | 2014 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 4 | 6 | 2008 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 3 | 3 | 2008 | 2019 | ||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
euchromatic histone lysine methyltransferase 2 | 0.590 | 0.808 | 1.0E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2014 | 2014 | ||||||||
|
inositol 1,4,5-trisphosphate receptor type 3 | 0.555 | 0.808 | 2.6E-22 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2008 | 2010 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2005 | 2014 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 8 | 8 | 2002 | 2020 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 6 | 3 | 2008 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2016 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.120 | None | 1.000 | 2 | 14 | 1990 | 2015 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.110 | None | 1.000 | 2 | 2 | 2008 | 2014 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 2 | 1 | 2008 | 2015 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.700 | None | 0.926 | 1 | 1 | 2009 | 2019 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 1 | 1 | 1995 | 2019 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
integrin subunit alpha X | 0.504 | 0.769 | 1.4E-15 |
|
disease | 0.150 | None | 1.000 | 1 | 2 | 2008 | 2019 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2014 | 2019 |